NICE. Guide to the methods of technology appraisal. London: National Institute for Health and Clinical Excellence; 2013.
Garau M, Shah K, Sharm P, Towse A. Is the link between health and wealth considered in decisionmaking? Results from a qualitative study. Int J Technol Assess Health Care. 2016;31:1–8.
Krol M, Papenburg J, Koopmmanschap M, Brouwer W. Do productivity costs matter? The impact of inlcuding productivity costs on the incremental costs of interventions targetted at depressive disorders. PharmacoEconomics. 2011;29:601–619.
Brouwer W, Rutten F, Koopmanschap M. Costing in economic evaluations. In: Drummond C, McGuire A, eds. Economic evaluation in health care: Merging theory with practice. Oxford: Oxford University Press; 2001:68–93.
Drummond M, Sculpher M, Torrance G, O'Brien B, Stoddart G. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press; 2005.
Sculpher M. The role and estimation of productivity costs in economic evaluation In: Drummond M, McGuire A, eds. Economic evaluation in health care: merging theory with practice. Oxford: Oxford University Press; 2001:94–112.
Olsen J, Richardson J. Production gains from health care: What should be included in cost-effectiveness analysis. Soc Sci Med. 1999;49:17–26.
Luce B, Manning W, Siegel J, Lipscomb J. Estimating costs in cost-effectiveness analysis. In: Gold M, Siegel J, Russell L, Weinstein M, eds. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996:176–213.
Lensberg B, Drummond M, Danchenko N, Despiegel N, Francois C. Challenges in measuring and valuing productivity costs, and their relevance in mood disorders. Clinicoecon Outcomes Res. 2013;5:565–573.
Zhang W, Bansback N, Anis A. Measuring and valuing productivity loss due to poor health: A critical review. Soc Sci Med. 2011;72:185–192.
Herrero C, Moreno-Ternero J. Estimating production costs in the economic evaluation of health-care programs. Health Econ. 2009;18:21–35.
Brouwer W, Koopmanscahp M, Rutten F. Productivity costs measurement through quality of life? A response to the recommendation of the Washington Panel. Health Econ. 1997;6:253–259.
Koopmanschap M, Rutten FFH, Vanineveld B, Vanroijen L. The friction cost method for measuring indirect costs of disease. J Health Econ. 1995;14:171–189.
Kigozi J, Jowett S, Lewis M, Barton P, Coast J. Estimating productivity costs using the friction cost approach in practice: a systematic review. Eur J Health Econ. 2016;17:31–44.
Morris S, Devlin N, Parkin D, Spencer A. Economic analysis in health care. 2nd ed. Chichester: Wiley; 2012.
Williams A. Cochrane lecture. All cost effective treatments should be free. . . or, how Archie Cochrane changed my life! J Epidemiol Community Health. 1997;51:116–120.
Richardson J. Economic assessment of health care: Theory and practice. Aust Econ Rev. 1991;24:4–21.
Claxton K, Sculpher M, Palmer S, Culyer A. Causes for concern: Is NICE failing to uphold its responsibilities to all NHS patients?
Health Econ. 2015;24:1–7.
Claxton K, Walker S, Palmer S, Sculpher M. Appropriate perspectives for health care decisions. York: Centre for Health Economics, 2010; Paper 54.
Mason H, Jones-Lee M, Donaldson C. Modelling the monetary value of a QALY: A new approach based on UK data. Health Econ. 2009;18:933–950.
McKie J, Richardson J. The rule of rescue. Soc Sci Med. 2003;56:2407–2419.
Arrow K. Uncertainty and the welfare economics of medical care. Am Econ Rev. 1963;53:941–973.
Brouwer W, Culyer A, van Exel N, Rutten F. Welfarism vs. extra-welfarism. J Health Econ. 2008;27:325–338.
Gerard K, Mooney G. QALY league tables: Handle with care. Health Econ. 1993;2:59–64.
Gold M, Siegel J, Russell L, Weinstein M. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.
The new politics of the NHS. 7th ed. London: Radcliffe Publishing; 2013.
Department of Health. The NHS Constitution for England. London: Department of Health; 2013.
Gottret P, Schieber G. Health financing revisited: A practitioner's guide. Washington DC: The World Bank; 2006.
Donaldson C, Gerard K. Economic of health care financing: The visible hand. 2nd ed.
Basingstoke: Palgrave Macmillan; 2005.
Layte R, Nolan A. Income-related inequity in the use of GP services by children: A comparison of Ireland and Scotland.
Eur J Health Econ. 2015;16:489–506.
Paulden M. Recent amendments to NICE's value-based assessment of health technologies: Implicitly inequitable?
Expert Rev Pharmacoecon Outcomes Res. 2017;17:239–242.
Walker S, Griffin S, Claxton K, Palmer S, Sculpher M. Appropriate perspectives for health care decisions. In: Curtis L, ed. Unit costs of health and social care 2012. Canterbury: Personal Social Services Research Unit; 2012:8–11.
Linley W, Hughes D. Societal views on NICE, cancer drugs fund and value based fundig criteria for prioritising medicines: A cross-sectional survey of 4118 adults in Great Britain.
Health Econ. 2013;22:948–964.